1. Home
  2. TECX vs FLOC Comparison

TECX vs FLOC Comparison

Compare TECX & FLOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • FLOC
  • Stock Information
  • Founded
  • TECX 2019
  • FLOC 1996
  • Country
  • TECX United States
  • FLOC United States
  • Employees
  • TECX N/A
  • FLOC N/A
  • Industry
  • TECX
  • FLOC Metal Fabrications
  • Sector
  • TECX
  • FLOC Industrials
  • Exchange
  • TECX Nasdaq
  • FLOC Nasdaq
  • Market Cap
  • TECX 387.1M
  • FLOC 417.7M
  • IPO Year
  • TECX 2018
  • FLOC 2025
  • Fundamental
  • Price
  • TECX $19.02
  • FLOC $15.06
  • Analyst Decision
  • TECX Buy
  • FLOC Strong Buy
  • Analyst Count
  • TECX 6
  • FLOC 6
  • Target Price
  • TECX $79.17
  • FLOC $30.17
  • AVG Volume (30 Days)
  • TECX 515.4K
  • FLOC 303.8K
  • Earning Date
  • TECX 11-06-2025
  • FLOC 11-05-2025
  • Dividend Yield
  • TECX N/A
  • FLOC 2.18%
  • EPS Growth
  • TECX N/A
  • FLOC N/A
  • EPS
  • TECX N/A
  • FLOC 3.01
  • Revenue
  • TECX N/A
  • FLOC $760,923,000.00
  • Revenue This Year
  • TECX N/A
  • FLOC $47.57
  • Revenue Next Year
  • TECX N/A
  • FLOC $8.16
  • P/E Ratio
  • TECX N/A
  • FLOC $4.87
  • Revenue Growth
  • TECX N/A
  • FLOC 155.05
  • 52 Week Low
  • TECX $13.70
  • FLOC $14.03
  • 52 Week High
  • TECX $61.07
  • FLOC $30.50
  • Technical
  • Relative Strength Index (RSI)
  • TECX 61.68
  • FLOC 48.32
  • Support Level
  • TECX $16.98
  • FLOC $14.06
  • Resistance Level
  • TECX $18.77
  • FLOC $15.29
  • Average True Range (ATR)
  • TECX 1.30
  • FLOC 0.64
  • MACD
  • TECX 0.54
  • FLOC 0.02
  • Stochastic Oscillator
  • TECX 96.12
  • FLOC 56.89

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About FLOC Flowco Holdings Inc. Class A Common Stock

Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.

Share on Social Networks: